Trial Profile

Phase I/II trial of AmpliPhage-001 in patients with cystic fibrosis-associated Pseudomonas aeruginosa infections

Status: Planning

Phase of Trial: Phase I/II

Latest Information Update: 22 Aug 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs AP PA01 (Primary)
Indications Cystic fibrosis-associated respiratory tract infections; Pseudomonal infections
Focus Adverse reactions; First in man
Sponsors AmpliPhi Biosciences Corporation

Most Recent Events

04 Aug 2016 Planned initiation date changed from 1 Jan 2016 to 1 Jan 2017, according to AmpliPhi Biosciences media release.
04 Aug 2016 According to AmpliPhi Biosciences media release, the company anticipates initiating a Phase 1 clinical trial in 2017.
12 Jun 2015 According to an AmpliPhi Biosciences media release, this trial is expected to being in 2016.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com